These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 33981659)

  • 21. Regional Differences, Dynamic Evolution and Convergence of Public Health Level in China.
    Li J; Xu M; Liu T; Zhang C
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Digital Economy on the Provision Efficiency for Public Health Services: Empirical Study of 31 Provinces in China.
    Lyu Y; Peng Y; Liu H; Hwang JJ
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Based on Contaminated Water and Human Health to Change of China's International Image Under Mainstream Media Reports During the COVID-19 Pandemic.
    Ji K; Zhou M; Yang Z; Zong H
    J Environ Public Health; 2022; 2022():7537056. PubMed ID: 36052353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.
    Duan W; Qin T
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience and Discussion: Safeguards for People With Disabilities During the COVID-19 Pandemic in China.
    Qi F; Wu Y; Wang Q
    Front Public Health; 2021; 9():744706. PubMed ID: 34805070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. China's community-based crisis management model for COVID-19: A zero-tolerance approach.
    Shangguan Z; Wang MY
    Front Public Health; 2022; 10():880479. PubMed ID: 35937237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How China controls the Covid-19 epidemic through public health expenditure and policy?
    Jin H; Li B; Jakovljevic M
    J Med Econ; 2022; 25(1):437-449. PubMed ID: 35289700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status and Challenges of Public Health Emergency Management in China Related to COVID-19.
    Cao Y; Shan J; Gong Z; Kuang J; Gao Y
    Front Public Health; 2020; 8():250. PubMed ID: 32574311
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of Internet Hospitals in China During the COVID-19 Pandemic: National Cross-Sectional Data Analysis Study.
    Xu X; Cai Y; Wu S; Guo J; Yang L; Lan J; Sun Y; Wang B; Wu J; Wang T; Huang S; Lin Y; Hu Y; Chen M; Gao X; Xie X
    J Med Internet Res; 2021 Jan; 23(1):e21825. PubMed ID: 33417586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflection and Foresight on Personal Information Protection and Optimization in Public Health Emergencies in China-From the Perspective of Personal Information Collection during the Period of China's Dynamic-Zero COVID-19 Prevention and Control Policy.
    Wang H
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. China's "dynamic clearing" epidemic prevention policy: Achievements, challenges, and prospects.
    Wang Q; Huang L
    Front Public Health; 2022; 10():978944. PubMed ID: 36187631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internet+ and COVID-19 - A short report.
    Chen J; Guo YC; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5176-5177. PubMed ID: 32432783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.
    Wang J; Wang Z
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32225019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
    Wang QC; Wang ZY
    Int J Clin Pract; 2021 Mar; 75(3):e13869. PubMed ID: 33264484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. China's policies: post-COVID-19 challenges for the older population.
    Wei X; Han G; Wang Q
    Glob Health Action; 2024 Dec; 17(1):2345968. PubMed ID: 38717833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding "Internet Plus Healthcare" in China: Policy Text Analysis.
    Yang F; Shu H; Zhang X
    J Med Internet Res; 2021 Jul; 23(7):e23779. PubMed ID: 34309581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on discourse right construction of China's medical aid to Africa].
    Li-Ying Z; Yao D; Kun Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Nov; 28(6):721-723. PubMed ID: 29469274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the nexus between COVID-19 pandemic-driven economic crisis and economic policy: lesson learned and challenges.
    Chang L; Mohsin M; Iqbal W
    Environ Sci Pollut Res Int; 2023 Feb; 30(9):22145-22158. PubMed ID: 36282386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.